The ILLUMINATE Studies are phase 2 clinical research studies evaluating an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingConsider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.
Continue ReadingConsider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.
Continue ReadingJoin the Solutions for Celiac Study where you get access to blood testing, symptom tracking tools, and celiac specialists focused on your disease.
Continue ReadingThe ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue Reading
